These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12457439)

  • 1. Novel therapies for sepsis: antiendotoxin therapies.
    Manocha S; Feinstein D; Kumar A; Kumar A
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1795-812. PubMed ID: 12457439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin as a drug target.
    Opal SM; Glück T
    Crit Care Med; 2003 Jan; 31(1 Suppl):S57-64. PubMed ID: 12544978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL; Guglielmo BJ
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiendotoxin strategies.
    Hellman J; Warren HS
    Infect Dis Clin North Am; 1999 Jun; 13(2):371-86, ix. PubMed ID: 10340172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors.
    Martin EL; Ranieri VM
    Contrib Nephrol; 2010; 167():65-76. PubMed ID: 20519900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on antiendotoxin therapies.
    Stephens R; Hamilton-Davies C
    Hosp Med; 2000 Apr; 61(4):254-8. PubMed ID: 10858802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic effects of endotoxin.
    Zivot JB; Hoffman WD
    New Horiz; 1995 May; 3(2):267-75. PubMed ID: 7583168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endotoxin response by synthetic TLR4 antagonists.
    Hawkins LD; Christ WJ; Rossignol DP
    Curr Top Med Chem; 2004; 4(11):1147-71. PubMed ID: 15279606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
    Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
    J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
    Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
    Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis.
    Opal SM
    Int J Med Microbiol; 2007 Sep; 297(5):365-77. PubMed ID: 17452016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The new antiendotoxin strategies].
    Wang DN; Zhang WJ; Wu XF
    Sheng Wu Gong Cheng Xue Bao; 2001 May; 17(3):241-5. PubMed ID: 11517592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants.
    Rubin RM; Noland J; Rosenbaum JT
    Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial responses to endotoxins and Gram-negative bacteria.
    Heumann D; Roger T
    Clin Chim Acta; 2002 Sep; 323(1-2):59-72. PubMed ID: 12135807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The application of molecular biology to anti-endotoxin therapies].
    Someya T; Sasaki K; Hirata K
    Nihon Geka Gakkai Zasshi; 2003 Jul; 104(7):523-6. PubMed ID: 12884777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.
    Wheeler DS; Zingarelli B; Wheeler WJ; Wong HR
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):96-112. PubMed ID: 19519586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.